Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Godavari Biorefineries Ltd

GODAVARIB
NSE
318.20
0.47%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Godavari Biorefineries Ltd

GODAVARIB
NSE
318.20
0.47%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,628Cr
Close
Close Price
318.20
Industry
Industry
Sugar
PE
Price To Earnings
72.32
PS
Price To Sales
0.81
Revenue
Revenue
2,003Cr
Rev Gr TTM
Revenue Growth TTM
5.11%
PAT Gr TTM
PAT Growth TTM
-174.78%
Peer Comparison
How does GODAVARIB stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
GODAVARIB
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
239398615523321447580533431460
Growth YoY
Revenue Growth YoY%
34.112.4-5.82.034.22.8
Expenses
ExpensesCr
271353501535354411467527439417
Operating Profit
Operating ProfitCr
-3245114-12-33361126-843
OPM
OPM%
-13.211.318.5-2.3-10.28.119.41.1-1.89.4
Other Income
Other IncomeCr
121131491-23-6
Interest Expense
Interest ExpenseCr
20182020201913151210
Depreciation
DepreciationCr
15161413121213141414
PBT
PBTCr
-651391-42-64896-22-5713
Tax
TaxCr
0-2626-1611324-6-155
PAT
PATCr
-653865-26-75672-16-428
Growth YoY
PAT Growth YoY%
-15.1-85.010.438.644.543.2
NPM
NPM%
-27.29.710.6-5.0-23.41.312.4-3.0-9.71.8
EPS
EPS
-15.59.215.5-6.2-17.91.314.1-3.1-8.11.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
1,4591,5381,7022,0151,6871,8702,003
Growth
Revenue Growth%
5.410.718.4-16.310.97.1
Expenses
ExpensesCr
1,3561,3811,5691,8681,5531,7671,850
Operating Profit
Operating ProfitCr
103158133146134104153
OPM
OPM%
7.110.37.87.37.95.57.7
Other Income
Other IncomeCr
148881417-19
Interest Expense
Interest ExpenseCr
69726073767251
Depreciation
DepreciationCr
45474850605053
PBT
PBTCr
346323212-230
Tax
TaxCr
-11913120227
PAT
PATCr
427192012-2323
Growth
PAT Growth%
568.4-29.72.8-37.4-290.4196.4
NPM
NPM%
0.31.81.11.00.7-1.31.1
EPS
EPS
1.06.54.54.72.9-5.14.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
42424242425151
Reserves
ReservesCr
385412431448459731674
Current Liabilities
Current LiabilitiesCr
8716509197681,110884386
Non Current Liabilities
Non Current LiabilitiesCr
136338342486381289353
Total Liabilities
Total LiabilitiesCr
1,4341,4421,7341,7441,9921,9551,463
Current Assets
Current AssetsCr
6446939798241,0761,023489
Non Current Assets
Non Current AssetsCr
790749754919915932974
Total Assets
Total AssetsCr
1,4341,4421,7341,7441,9921,9551,463

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
250130451971856
Investing Cash Flow
Investing Cash FlowCr
-23-7-48-214-44-69
Financing Cash Flow
Financing Cash FlowCr
-226-121628-15164
Net Cash Flow
Net Cash FlowCr
12311-101
Free Cash Flow
Free Cash FlowCr
223119-5-20130-65
CFO To PAT
CFO To PAT%
6,142.5478.5234.91,003.01,505.7-26.3
CFO To EBITDA
CFO To EBITDA%
241.582.433.8134.7138.75.9

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00000751
Price To Earnings
Price To Earnings
0.00.00.00.00.00.0
Price To Sales
Price To Sales
0.00.00.00.00.00.4
Price To Book
Price To Book
0.00.00.00.00.01.0
EV To EBITDA
EV To EBITDA
5.13.44.44.74.711.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.531.330.231.330.225.9
OPM
OPM%
7.110.37.87.37.95.5
NPM
NPM%
0.31.81.11.00.7-1.3
ROCE
ROCE%
7.211.68.38.57.65.5
ROE
ROE%
0.96.04.04.02.5-3.0
ROA
ROA%
0.31.91.11.10.6-1.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Godavari Biorefineries Limited (**GBL**), a flagship of the **Somaiya Group**, is a leading Indian integrated biorefinery and a pioneer in "Green Chemistry." The company utilizes a circular economy model to transform sugarcane and other biomass into a diversified portfolio of high-value products, including **sugar**, **ethanol**, **bio-based specialty chemicals**, and **renewable power**. Following its **October 2024 IPO**, GBL is aggressively transitioning from a traditional sugar processor into a high-margin specialty chemicals and life sciences innovator. --- ### **Integrated Manufacturing & Infrastructure Strategy** GBL operates two strategically located manufacturing facilities in high-recovery sugarcane regions, supported by three **DSIR-registered R&D centers**. | Facility | Location | Primary Operations | Key Capacities (as of 2024-25) | | :--- | :--- | :--- | :--- | | **Sameerwadi** | Karnataka | Sugar, Distillery, Co-generation | **20,000 TCD** Crushing; **570 KLPD** Ethanol; **45+ MW** Power | | **Sakarwadi** | Maharashtra | Bio-based Specialty Chemicals | Production of **Ethyl Acetate**, **MPO**, **1,3 Butylene Glycol** | * **Record Operational Performance:** In the **2025-26** crushing session, the Sameerwadi unit achieved its highest-ever crushing of **0.25 crore tonnes**. * **Feedstock Diversification:** To mitigate agri-climatic and regulatory risks, GBL is commissioning a **200 KLPD grain-based distillery** (expected **Q1 FY27**). This enables a fungible, dual-feedstock model (rice/maize) to ensure year-round distillery utilization. * **Energy Self-Sufficiency:** **84-85%** of total energy consumption is derived from renewable sources, primarily **bagasse**. The company is a net exporter of green power to the grid and operates a **1 MW** solar plant with an additional **500 KW** planned for 2026. --- ### **Business Segments & Revenue Mix** The company’s integrated model allows it to pivot production based on market conditions and government policy (e.g., ethanol blending mandates). | Segment | Revenue Contribution (FY25) | Key Products / Brands | Strategic Focus | | :--- | :--- | :--- | :--- | | **Sugar & Co-gen** | **36%** | Refined/Brown sugar, Jaggery; **Jivana** | Transitioning to retail/branded sales. | | **Distillery** | **31%** | Fuel Ethanol, Rectified Spirits, **ENA** | Supporting India’s **20% blending target**. | | **Bio-based Chemicals** | **29%** | Ethyl Acetate, **MPO**, **1,3 Butylene Glycol** | High-margin "Green Chemistry" for global markets. | * **Bio-based Chemicals Leadership:** GBL is the **sole producer of bio-ethyl acetate** in India and one of only two global manufacturers of **natural 1,3 butylene glycol**. Specialty chemicals now account for **62%** of this segment's revenue. * **Consumer Brand (Jivana):** The retail brand has expanded from **2,200** outlets in FY23 to over **7,500** outlets in 9M FY26. It achieved **15X** gross sales growth on Zepto within one year of listing. * **Global Reach:** GBL exports to over **34 countries**, including the USA, EU, Japan, and Australia, serving blue-chip clients such as **Hershey's India**, **Coca-Cola**, **Synthomer**, and **LANXESS**. --- ### **R&D, Biotechnology, and Climate Innovation** GBL maintains a heavy focus on original research, employing over **50 researchers** and holding **54 patent registrations** globally. * **Sathgen Therapeutics:** This division is developing novel small molecules for **Triple-Negative Breast Cancer (TNBC)**. Phase I safety trials were successfully concluded with no dose-limiting toxicity. GBL incorporated **Sathgen Therapeutics LLC** (USA) in 2025 to facilitate global IP licensing. * **Climate Technology:** GBL developed the **world’s first one-step process** to convert biogenic **CO2 and Hydrogen directly into Dimethyl Ether (DME)**, a clean fuel substitute for LPG. * **Advanced Bio-Alcohols:** Secured an exclusive India license from **Catalyxx Inc.** to produce up to **30,000 MTPA** of biobutanol and higher alcohols. * **2G Ethanol:** Developing a demonstration plant for **second-generation ethanol** using bagasse, supported by a **₹15 crore** government grant. --- ### **Financial Performance & Deleveraging** The **October 2024 IPO** raised **₹554.75 crore**, which fundamentally restructured the balance sheet. | Metric (Consolidated) | FY 2023-24 | FY 2024-25 | | :--- | :--- | :--- | | **Revenue from Operations** | **₹1,686.67 Cr** | **₹1,870.25 Cr** | | **EBITDA Margin** | **9.0%** | **6.0%** | | **Debt-to-Equity Ratio** | **2.55x** | **0.91x** | | **Current Ratio** | **0.95** | **1.13** | | **Total Debt/PBILDT** | **4.53x** | **4.93x** | * **Debt Reduction:** GBL utilized **₹240 crore** from IPO proceeds to prepay high-cost debt, reducing annual repayment burdens to **₹36 crore** from FY26 onwards. * **Profitability Targets:** The company is targeting an **EBITDA increase of ~3x** of FY25 levels by **FY29**, driven by the shift toward specialty chemicals. * **Credit Ratings:** **CARE Ratings** reaffirmed **CARE BBB+; Stable** (Long-term) and **CARE A2** (Short-term) in March 2026. --- ### **Risk Factors & Contingent Liabilities** GBL operates in a complex regulatory and agro-climatic environment that introduces significant volatility. * **Regulatory Exposure:** Profitability is sensitive to the **Fair and Remunerative Price (FRP)** of sugarcane (increased to **₹355/quintal** for 2025-26) and government-mandated ethanol procurement prices. * **Seasonality & Working Capital:** Operations are concentrated in **H2** (Nov–April), leading to high inventory holding periods of **155-160 days** and fund-based limit utilization of **~94%**. * **Legal & Tax Headwinds:** * **GST Dispute:** A demand of **₹46.85 crore** (plus penalty) regarding GST on **Extra Neutral Alcohol (ENA)** is currently stayed by the Karnataka High Court. * **Income Tax:** Outstanding demands for **AY 2021-22** and **AY 2023-24** totaling over **₹73 crore** are under appeal. * **Environmental:** Ongoing NGT/CPCB investigations regarding pollution allegations with a final hearing scheduled for **June 2025**. * **Agro-Climatic Risk:** Dependence on monsoon patterns affects sugarcane recovery rates (currently **~11%**) and crushing duration.